By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Phone: Fax:



Company News
PTC Therapeutics (PTCT) Announces Publication Of Data From ACT DMD In The Lancet 7/18/2017 8:03:21 AM
Spark Therapeutics (ONCE) Announces Publication In The Lancet Of Pivotal Phase III Clinical Trial Data For Investigational Voretigene Neparvovec 7/14/2017 10:41:07 AM
Skin Patch May Be The Future Of Flu Vaccines, Lancet Reveals 6/28/2017 6:11:20 AM
Pfizer (PFE) Announces Results From XELJANZ (Tofacitinib Citrate) ORAL Strategy Study Published In The Lancet And Presented At The EULAR Annual Congress 6/16/2017 6:58:29 AM
Takeda (TKPYY) And Seattle Genetics (SGEN) Announce Lancet Publication Of Phase III Alcanza Clinical Trial Data Of Adcetris (Brentuximab Vedotin) For CD30-Positive Cutaneous T-Cell Lymphoma 6/7/2017 7:41:56 AM
The Lancet Publishes Phase ll Results From Shire (SHPG)'s Investigational Anti-MAdCAM Antibody Showing Significantly Increased Remission Rates In Patients With Moderate-To-Severe Ulcerative Colitis 5/18/2017 7:44:57 AM
Celltrion Healthcare (068270.KQ): Lancet Publishes Full Data-Set From Influential NOR-SWITCH Study 5/12/2017 6:48:52 AM
Summit Therapeutics: Phase II CoDIFy Trial Results Published In Lancet Infectious Diseases 5/2/2017 10:58:54 AM
Phase II CoDIFy Trial Results Published In Lancet Infectious Diseases With Data Showing Summit Therapeutics’s Ridinilazole Achieved Statistical Superiority Over Vancomycin In The Treatment Of C. Difficile Infection 5/1/2017 11:56:07 AM
Positive Results Of Phase IIb Clinical Trial Of Pharmalink AB's Nefecon In Primary IgA Nephropathy Published In The Lancet 3/29/2017 7:37:37 AM